Latest News about ALLO
Recent news which mentions ALLO
From Benzinga
 
   What 5 Analyst Ratings Have To Say About Allogene Therapeutics
   
  August 10, 2022
  Tickers 
   ALLO
  
  
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022
   
  
  
  August 10, 2022
  From Benzinga
 
   Why Beam Therapeutics Stock Dipped Today
   
  
  
  August 01, 2022
  From Motley Fool
 From Benzinga
 From Benzinga
 From Benzinga
 
   89 Biggest Movers From Friday
   
  
  
  June 21, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Allogene's Preclinical Data Show Healthy Donor-Derived Allogeneic CAR T Cells Have Better Immune Fitness, Killing Activity
   
  
  
  March 23, 2022
  From Benzinga
 
   Why Cellectis Stock Rose 20.7% This Week
   
  
  
  March 10, 2022
  From Motley Fool
 
   Stocks That Hit 52-Week Lows On Wednesday
   
  
  
  February 16, 2022
  From Benzinga
 
   FDA Lifts Clinical Hold On Allogene's CAR-T Trials
   
  
  
  January 11, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  December 20, 2021
  From Benzinga
 
   58 Biggest Movers From Yesterday
   
  
  
  December 14, 2021
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Intraday Session
   
  
  
  December 13, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
   
  
  
  December 12, 2021
  From Benzinga
 
   Being First Is Not Enough For Crispr Therapeutics
   
  
  
  November 15, 2021
  From InvestorPlace
 
   Cathie Wood's Buying Beam Therapeutics -- Should You?
   
  
  
  November 09, 2021
  From Motley Fool
 
   Allogene Therapeutics Inc (ALLO) Q3 2021 Earnings Call Transcript
   
  November 05, 2021
  Tickers 
   ALLO
  
  
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.